Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3 publications
Clinical utility of a multianalyte lupus risk score incorporating cell-bound complement activation products: a systematic evaluation.
Journal: Lupus science & medicine
Published: February 06, 2026
Glucagon-Like Peptide-1 Receptor Agonist Treatment Attributes Important to Injection-Experienced Patients with Type 2 Diabetes Mellitus: A Preference Study in Germany and the United Kingdom.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: January 03, 2017
Glucagon-like Peptide-1 Receptor Agonist Treatment Attributes Important to Injection-Naïve Patients with Type 2 Diabetes Mellitus: A Multinational Preference Study.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: December 07, 2016
Showing 1-3 of 3
Last Updated: 09/26/2026